Green Your Life interior

More Proof Heartburn Products Are Dangerous

Researchers from University College London and The University of Hong Kong found the risk of developing stomach cancer more than doubled when an individual took PPIs. To factor the potential role the infection plays in the development of stomach cancer, the researchers compared the use of PPIs to reduce acid reflux against people treated with triple therapy to kill H. pylori and then with H2 receptor antagonists such as Pepcid, Tagamet or Zantac. Read more...

 

Back

 
 
close (X)